Equitable access to direct-acting antivirals: Canada's path to a hepatitis C-free tomorrow [0.03%]
直接抗病毒药物的公平获取：加拿大消除丙型肝炎的道路
Faranak Canani,Jordan J Feld,Mia J Biondi
Faranak Canani
Identifying patients with diagnosed cirrhosis in administrative health databases: a validation study [0.03%]
基于行政健康数据库识别诊断为肝硬化患者的验证性研究
Nabiha Faisal,Lisa M Lix,Randy Walld et al.
Nabiha Faisal et al.
Objectives: Case ascertainment algorithms were developed and validated to identify people living with cirrhosis in administrative health data in Manitoba, Canada using primary care electronic medical records (EMR) to defi...
Factors associated with knowledge and awareness of Hepatitis B in individuals of Chinese descent: Results from a mass point of care testing and outreach campaign in Toronto, Canada [0.03%]
多中心临床研究发现乙型肝炎病毒感染者接受抗病毒治疗的危险因素分析
Andrew B Mendlowitz,Erin Mandel,Camelia I Capraru et al.
Andrew B Mendlowitz et al.
Background: Migrants from hepatitis B virus (HBV) endemic regions are at high risk of having chronic infection. Despite this, HBV knowledge and awareness programming, and low-barrier screening methods such as point of car...
Eric M Yoshida,Natasha Chandok
Eric M Yoshida
Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis [0.03%]
奶蓟素对代谢功能异常相关肝脂肪变性的影响：系统评价和 Meta 分析
Adnan Malik,Muhammad Malik,Shahbaz Qureshi
Adnan Malik
Background: Fatty liver disease comprises a wide range of related liver disorders affecting mainly people who drink no or minimal amounts of alcohol. Silymarin is a member of the Carduus marianum family that has been used...
Karen Stacey
Karen Stacey
Development and validation of a case definition to estimate the prevalence and incidence of cirrhosis in pan-Canadian primary care databases [0.03%]
在全加拿大初级保健数据库中估计肝硬化的流行率和发病率的病例定义的建立与验证
Nabiha Faisal,Leanne Kosowan,Hasan Zafari et al.
Nabiha Faisal et al.
Aims: To develop and validate case definitions to identify patients with cirrhosis and alcohol-related cirrhosis using primary care electronic medical records (EMRs) and to estimate cirrhosis prevalence and incidence in p...
Comparison of different definitions of metabolic syndrome and their associations with non-alcoholic fatty liver disease: a retrospective study [0.03%]
不同代谢综合征定义的比较及其与非酒精性脂肪肝疾病的联系：一项回顾性研究
Carmen Tse,Nicholas Lisanti,Micah Grubert Van Iderstine et al.
Carmen Tse et al.
Background: Metabolic syndrome (MetS) is considered an important risk factor for non-alcoholic fatty liver disease (NAFLD). The aim of this study was to measure the prevalence of MetS based on six different MetS definitio...
Canadian trends in spending on liver hospitalizations and transplants: 2004-2020 [0.03%]
2004-2020年加拿大肝脏住院和移植费用的变化趋势
Keqing Zhao,Ahmad Shakeri,Pooyeh Graili et al.
Keqing Zhao et al.
Background: The incidence and prevalence of liver disease are increasing and contribute to significant morbidity and mortality. In Canada, more than 3 million people live with liver diseases, accounting for approximately ...